Cefdinir - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for cefdinir and what is the scope of patent protection?

Cefdinir is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Anda Repository, Aurobindo Pharma, Lupin, Sandoz, Teva Pharms, and Abbvie, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for cefdinir. Twenty-eight suppliers are listed for this compound.

Sponsor	Phase
Assistance Publique - Hôpitaux de Paris	Phase 4
Mercy Health Ohio	Phase 2
Northeast Ohio Medical University	Phase 2

Sponsor

Phase

Assistance Publique - Hôpitaux de Paris

Phase 4

Mercy Health Ohio

Phase 2

Northeast Ohio Medical University

Phase 2

US Patents and Regulatory Information for cefdinir

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Anda Repository	CEFDINIR	cefdinir	FOR SUSPENSION;ORAL	065429-001	Jul 18, 2007	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alkem Labs Ltd	CEFDINIR	cefdinir	FOR SUSPENSION;ORAL	210534-002	Feb 19, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms	CEFDINIR	cefdinir	CAPSULE;ORAL	065368-001	May 9, 2007	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alkem Labs Ltd	CEFDINIR	cefdinir	FOR SUSPENSION;ORAL	210534-001	Feb 19, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Anda Repository	CEFDINIR	cefdinir	CAPSULE;ORAL	065418-001	Jul 18, 2007	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms	CEFDINIR	cefdinir	FOR SUSPENSION;ORAL	065332-002	May 4, 2007	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma	CEFDINIR	cefdinir	CAPSULE;ORAL	065434-001	Jan 7, 2008	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	OMNICEF	cefdinir	CAPSULE;ORAL	050739-001	Dec 4, 1997	⤷ Sign Up	⤷ Sign Up
Abbvie	OMNICEF	cefdinir	FOR SUSPENSION;ORAL	050749-002	Jul 29, 2004	⤷ Sign Up	⤷ Sign Up
Abbvie	OMNICEF	cefdinir	FOR SUSPENSION;ORAL	050749-001	Dec 4, 1997	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

CAPSULE;ORAL

Dec 4, 1997

⤷ Sign Up

FOR SUSPENSION;ORAL

Jul 29, 2004

⤷ Sign Up

FOR SUSPENSION;ORAL

Dec 4, 1997

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	0
Tradenames:	2
Applicants:	7
NDAs:	14
Drug Master File Entries:	12
Finished Product Suppliers / Packagers:	28
Raw Ingredient (Bulk) Api Vendors:	68
Clinical Trials:	27
Patent Applications:	7,477
Drug Prices:	Drug price trends for cefdinir
Drug Sales Revenues:	Drug sales revenues for cefdinir
What excipients (inactive ingredients) are in cefdinir?	cefdinir excipients list
DailyMed Link:	cefdinir at DailyMed

Cefdinir - Generic Drug Details

What are the generic sources for cefdinir and what is the scope of patent protection?

Summary for cefdinir

Recent Clinical Trials for cefdinir

Pharmacology for cefdinir

Anatomical Therapeutic Chemical (ATC) Classes for cefdinir

US Patents and Regulatory Information for cefdinir

Expired US Patents for cefdinir

Make Better Decisions: Try a trial or see plans & pricing